Pityriasis rosea
pityriasis rosea, herald patch, Christmas tree distribution, HHV-6, HHV-7 · Dermatology
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
Common self-limiting papulosquamous eruption, probably linked to HHV-6/7 reactivation, typically in adolescents and young adults. A single 'herald patch' is followed over days-weeks by a symmetrical truncal eruption of oval scaly macules along skin cleavage lines ('Christmas-tree' pattern). Resolves spontaneously over 6-12 weeks. Key is to exclude secondary syphilis and drug eruptions.
Red flags
- Palmoplantar lesions, mucous patches, generalised lymphadenopathy, or sexual risk - exclude secondary syphilis
- Atypical distribution/morphology or failure to resolve by 3 months - reconsider diagnosis/biopsy
- New medication preceding eruption - pityriasis rosea-like drug eruption (may not self-resolve)
- Widespread pityriasis rosea in early pregnancy (counsel/monitor)
Assessment
Differential diagnosis
- Secondary syphilis (palms/soles, lymphadenopathy, mucous patches - MUST exclude)
- Guttate psoriasis
- Tinea corporis (herald patch mimic - KOH)
- Nummular eczema
- Pityriasiform drug eruption (ACEi, NSAIDs, antimalarials, some biologics)
- Viral exanthem
- Pityriasis lichenoides
Investigations
- Clinical diagnosis (herald patch + collarette scale + cleavage-line distribution)
- Syphilis serology (RPR/VDRL + treponemal) if any atypia, palmoplantar involvement, mucosal lesions, lymphadenopathy, or sexual risk
- KOH of herald patch if tinea suspected
- Medication review for pityriasis rosea-like drug eruption
- No routine bloods otherwise
Management
- Confirm clinical diagnosis and reassure - self-limiting, not contagious, resolves in 6-12 weeks
- Exclude secondary syphilis (serology) when any atypical feature, palm/sole lesions or sexual risk
- Symptomatic relief: emollient; mild-moderate topical corticosteroid and/or oral antihistamine for itch
- Advise that post-inflammatory pigment change may persist (esp. darker skin) but fades
- Severe/extensive/very itchy or persistent: consider NB-UVB phototherapy; some evidence for oral aciclovir early in course to speed resolution [verify local]
- In pregnancy: usually benign but counsel re small reported risk in early widespread disease - involve obstetrics if concerned
Drugs & doses
Emollient liberally for scale and comfort
Mild-moderate topical corticosteroid (e.g. hydrocortisone 1% or clobetasone butyrate 0.05%) once-twice daily for itch
Oral antihistamine (e.g. cetirizine 10 mg ORAL once daily, or sedating chlorphenamine at night) for pruritus
Aciclovir 800 mg ORAL five times daily for 7 days early (within first week) may hasten resolution in severe cases [verify local dose]
NB-UVB phototherapy for severe/persistent itch [verify local]
Disposition
Discharge with reassurance and symptomatic advice. GP follow-up if not resolving by 3 months or atypical. Syphilis screening where indicated; dermatology referral only for diagnostic doubt or severe/persistent disease.
Complications & pitfalls
- Post-inflammatory hyper/hypopigmentation (usually temporary)
- Persistent pruritus
- Rare prolonged or recurrent course
- Reported association with adverse pregnancy outcome if widespread in first 15 weeks (uncertain)
Exam pearls
- Herald patch + collarette of fine scale + 'Christmas-tree' truncal pattern along Langer's lines is diagnostic
- Always consider secondary syphilis - 'the great imitator' - if palms/soles involved or any risk; check serology
- Self-limiting: reassurance and symptomatic treatment are usually all that is needed
- A pityriasis rosea-like drug eruption will not self-resolve - review the drug chart
- Early oral aciclovir has limited evidence for shortening severe cases
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.